Synapse

← Stephan Windecker

Papers by Stephan Windecker

Page 5 · newest first

  1. Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid RegurgitationJournal of the American Heart Association · 2023
  2. Transcatheter Mitral Valve Replacement or Repair for Secondary Mitral Regurgitation: A Propensity Score-Matched AnalysisEuropean Journal of Heart Failure · 2023
  3. Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trialCatheterization and Cardiovascular Interventions · 2023
  4. Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE CooperationCirculation · 2023
  5. Valve-in-valve TAVI and risk of coronary obstruction: Validation of the VIVID classificationJournal of cardiovascular computed tomography · 2023
  6. Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovationEuropean Heart Journal · 2023
  7. Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort studyFrontiers in Cardiovascular Medicine · 2023
  8. Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 RegistriesCirculation Cardiovascular Interventions · 2023
  9. Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantationCatheterization and Cardiovascular Interventions · 2022
  10. Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitationEuropean Heart Journal · 2022
  11. Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIJournal of the Society for Cardiovascular Angiography & Interventions · 2022
  12. Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacementEuroIntervention · 2022
  13. Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2EuroIntervention · 2022
  14. Invasive electrophysiological testing to predict and guide permanent pacemaker implantation after transcatheter aortic valve implantation: A meta-analysisHeart Rhythm O2 · 2022
  15. SGLT2 Inhibitor Therapy for Transthyretin Amyloid Cardiomyopathy: Early Tolerance and Clinical Response to DapagliflozinESC Heart Failure · 2022
  16. Therapeutic Management of Anomalous Coronary Arteries Originating From the Opposite Sinus of Valsalva: Current Evidence, Proposed Approach, and the UnknowingJournal of the American Heart Association · 2022
  17. Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow upEuropean Heart Journal · 2022
  18. Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding RiskJournal of the American College of Cardiology · 2022
  19. Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trialCatheterization and Cardiovascular Interventions · 2022
  20. Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical TrialsCirculation · 2022
  21. CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical researchThe Lancet Digital Health · 2022
  22. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical researchBMJ · 2022
  23. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk PatientsJAMA Cardiology · 2022
  24. Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsJournal of the Society for Cardiovascular Angiography & Interventions · 2022
  25. Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE ClearJournal of the Society for Cardiovascular Angiography & Interventions · 2022
  26. Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.2022
  27. Smoking cessation and depression after acute coronary syndromePreventive Medicine · 2022
  28. Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after studySwiss Medical Weekly · 2022
  29. Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarctionFrontiers in Cardiovascular Medicine · 2022
  30. Risk and Timing of Noncardiac Surgery After Transcatheter Aortic Valve ImplantationJAMA Network Open · 2022
  31. Guideline‐directed medical therapy in patients undergoing transcatheter edge‐to‐edge repair for secondary mitral regurgitationEuropean Journal of Heart Failure · 2022
  32. Smoking Cessation in People With and Without Diabetes After Acute Coronary SyndromeNicotine & Tobacco Research · 2022
  33. Imaging-Based, Patient-Specific Three-Dimensional Printing to Plan, Train, and Guide Cardiovascular Interventions: A Systematic Review and Meta-AnalysisHeart Lung and Circulation · 2022
  34. Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior StrokeJAMA Cardiology · 2022
  35. Assessment of New Onset Arrhythmias After Transcatheter Aortic Valve Implantation Using an Implantable Cardiac MonitorFrontiers in Cardiovascular Medicine · 2022
  36. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trialCatheterization and Cardiovascular Interventions · 2022
  37. Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantationEuroIntervention · 2022
  38. Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantationBMC Cardiovascular Disorders · 2022
  39. Translating Imaging Into 3D Printed Cardiovascular PhantomsJACC Basic to Translational Science · 2022
  40. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial InfarctionJAMA · 2022
  41. Long-term outcomes of new-onset conduction abnormalities following transcatheter aortic valve implantationArchives of cardiovascular diseases · 2022
  42. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS TrialJournal of the American Heart Association · 2022
  43. Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes MellitusJournal of the Society for Cardiovascular Angiography & Interventions · 2022
  44. Impact of First-Phase Ejection Fraction on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve ImplantationCardiovascular revascularization medicine · 2022
  45. Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?European Heart Journal · 2022
  46. Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantationCatheterization and Cardiovascular Interventions · 2022
  47. Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classificationPLoS ONE · 2022
  48. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL studyEP Europace · 2022
  49. Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trialOpen Heart · 2022
  50. Reproducibility of 4D cardiac computed tomography feature tracking myocardial strain and comparison against speckle-tracking echocardiography in patients with severe aortic stenosisJournal of cardiovascular computed tomography · 2022